About
Partner at Maiwald GmbH, Andreas Ledl is a German and European patent attorney, UPC representative and biochemist who advises on IP protection in pharmaceuticals, biotechnology and biochemistry. He has extensive experience in patent prosecution, EPO opposition and appeal proceedings, and patent portfolio strategy including freedom-to-operate, validity and due diligence analyses.
Practice areas
Intellectual PropertyPatent ProsecutionOppositions & AppealsPatent Portfolio ManagementLife SciencesBiotechnologyPharmaceuticals
Office
Expertise
Patent prosecutionOpposition and appeal proceedings before the European Patent OfficePatent portfolio strategy and managementFreedom-to-operate, validity and due diligence analysesPharmaceuticals, biotechnology and biochemistry
Education
- Studied biochemistry, University of Regensburg and Wesleyan University (1995–2001)
- Doctoral degree in Biochemistry, Ludwig Maximilian University of Munich; doctoral research at the Max Planck Institute of Biochemistry (2001–2006)
- Studied law for patent attorneys, University of Hagen (2006–2009)
Admissions
- Admitted to practice before the Unified Patent Court (2023)
- Admitted as European Patent Attorney (2010)
- Admitted as German Patent Attorney (2010)
Languages
GermanEnglish